Anal Fistula Plug, a Retrospective Study
Launched by ZHEN JUN WANG · Mar 21, 2020
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
Treatment of anal fistulas, especially involving significant anal sphincters, continues to represent a challenge for surgeons. Surgery has been the mainstay of treatment, and the ideal goal of anal fistula treatment is to obliterate the fistulous tract, while preserving the anal sphincter and avoiding fecal incontinence. The anal fistula plug is a sphincter-sparing procedure that uses biological substances to close an anorectal fistula. Several studies have preliminarily shown that the anal fistula plug had advantages of simple and repeatable application, preservation of sphincter integrity,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with trans-sphincteric anal fistula.
- • The case information was complete.
- • Not receive other treatment previously.
- Exclusion Criteria:
- • Fistulas related to Crohn's disease, ulcerative colitis or anorectal tumors.
- • Underwent surgical incision and drainage for acute perianal infections within 3 months.
- • Multiple fistula tracts \> 2.
- • Poor underlying condition and unable to tolerate surgery.
About Zhen Jun Wang
Zhen Jun Wang is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on enhancing patient care, the organization specializes in designing and conducting clinical trials across various therapeutic areas. Zhen Jun Wang leverages a robust network of experienced professionals and cutting-edge methodologies to ensure rigorous study protocols and regulatory compliance. Committed to ethical practices and transparency, the sponsor aims to contribute valuable insights to the medical community, ultimately facilitating the development of effective treatments and improving health outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Jiagang Han
Study Director
Beijing Chao Yang Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials